We will rely on you to help lend your voice and support the biotechnology industry.
Bringing new treatments to patients, support public policies that promote innovation, improve patient access.
BIO Latin America Conference
September 4-5, 2018
BIO Investor Forum
October 17-18, 2018
BIO Industry Analysis Reports >>
Save. Advocate. Connect. Join Us.
A listing of all BIO members and subsidiaries.
October 17 - 18, 2018 | San Francisco, California
Yoram loves bringing new technologies to market, and has successfully led that as an executive in several med-tech companies over the last 20 years. Until joining Nobio in 2017 as CEO, Yoram ran the international business for Atlanta-based EndoChoice, provider of innovative products and services for the GI endoscopy market. EndoChoice completed an IPO on NYSE in June 2015 and was acquired by Boston Scientific in November 2016. During 2007-2013 Yoram was CEO of Israel-based biopharma Aposense, developer of novel therapies and imaging agents targeting cells undergoing apoptosis (programmed cell death). In 2010 Aposense completed an IPO on the TASE. During 2000-2006 Yoram was Vice President, Business Development of Israel-based Given Imaging, manufacturer of the first and current market leader of capsule endoscopy, for non-invasive examination of the intestines, which completed an IPO on Nasdaq in 2001 and in 2013 was acquired by Covidien (now part of Medtronic).
This speaker's sessions: